Why Prestige Consumer Healthcare (PBH) is a Top Momentum Stock for the Long-TermZacks Investment Research • 02/29/24
Prestige Consumer Healthcare (PBH) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research • 02/08/24
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Due to the Presence of BenzeneGlobeNewsWire • 02/02/24
Prestige Consumer Healthcare (PBH) Reports Next Week: What Awaits?Zacks Investment Research • 02/01/24
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings ResultsGlobeNewsWire • 01/10/24
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of BenzeneGlobeNewsWire • 12/22/23
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder Due to the Presence of BenzeneGlobeNewsWire • 11/24/23
Here's What Key Metrics Tell Us About Prestige Consumer Healthcare (PBH) Q2 EarningsZacks Investment Research • 11/02/23
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings ResultsGlobeNewsWire • 10/05/23
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Growth StockZacks Investment Research • 09/29/23
Why Prestige Consumer Healthcare (PBH) is a Top Growth Stock for the Long-TermZacks Investment Research • 09/11/23
Down -11.27% in 4 Weeks, Here's Why You Should You Buy the Dip in Prestige Consumer Healthcare (PBH)Zacks Investment Research • 09/06/23